Bioavailability enhancement

Abstract Background: The therapeutic potential of many natural products, including curcumin (CUR), betulinic acid (BA), and oleanolic acid (OA), is limited...

IOI Oleo launched a new family of functional, lipid-based excipients, the polyglycerol esters at CPhI 2025. As the CPhI 2026...

A significant proportion of new drug candidates present limited aqueous solubility. This is a well-documented formulation challenge, particularly for oral...

Abstract Aceclofenac (ACF) is a commonly used non-steroidal anti-inflammatory drugs (NSAID) for numerous inflammatory conditions; however, its therapeutic potential is...

Abstract Propolis is a widely studied natural raw material, the composition of which varies depending on the plant origin, harvest...

Abstract Purpose Simvastatin (SIM) is a widely prescribed lipid-lowering agent; however, its clinical efficacy is hindered by poor aqueous solubility...

AI in pharmaceutical drug product design is, in 2026, a decision-support technology, not autonomous formulation. The most mature tools combine...

Amphiphilic, non-ionic block copolymers suitable for diverse pharmaceutical applications Did you know? Kolliphor® P grade poloxamers are among the most...

Abstract Biomacromolecules including peptides, proteins, antibodies, and gene medicines, comprise important classes of therapeutics in treating disease. A drawback of...

Abstract The anti-glaucoma drug betaxolol hydrochloride (BH) exhibits poor ocular bioavailability due to limited corneal permeability, rapid precorneal loss, short...